Tryn Stimart - 07 Dec 2021 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role: Chief Legal Officer
Signature: /s/ Tryn Stimart
Issuer symbol: ABCL
Transactions as of: 07 Dec 2021
Net transactions value: $0
Form type: 4
Filing time: 09 Dec 2021, 16:55:42 UTC
Previous filing: 10 Jun 2021
Next filing: 05 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ABCL	Common Shares						250	07 Dec 2021	Direct
holding	ABCL	Common Shares						250	07 Dec 2021	By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ABCL	Share Option (right to buy)	Award	$0	+270,680	+13%	$0.000000	2,311,480	07 Dec 2021	Common Shares	270,680	$14.55	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on December 7, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date